Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Balloon-expandable TAVR valves linked to superior 1-year outcomes

Asian patients are rarely represented in large TAVR trials, the authors wrote, so they focused on nearly 1,200 patients from South Korea to provide a fresh perspective. 

Newsweek ranked the 50 best heart hospitals in the world

Hybrid coronary revascularization vs. CABG for multivessel CAD: New meta-analysis tracks long-term outcomes

A hybrid approach may increase the risk of certain adverse events, according to a new meta-analysis focused on long-term outcomes. 

HeartMate 3 LVAD abbott

Former FDA employees share concerns about heart device safety data

Abbott's HeartMate 3 LVAD is the only FDA-approved device of its kind currently available in the United States. Should reports of adverse events worry cardiologists? Or are they to be expected when treating such a vulnerable patient population?

SimonMed

Imaging chain dramatically improves diagnosis of fractures with AI

SimonMed achieved an 82% improvement in X-ray reading time using the technology. 

Michael Lipton, MD, PhD, from Columbia University’s Vagelos College of Physicians

Heading a soccer ball linked to reduced brain function

Until now, little was known about the impact of long-term use of the technique.

doctor in handcuffs after being arrested

Cardiologist charged with fraud for allegedly altering patient records, billing for unnecessary procedures

The doctor allegedly targeted some patients more than ten times, treating them again and again with procedures that were not medically necessary. 

business launch

‘A true breakthrough’: The eye-opening potential of GLP-1 agonists to treat heart, kidney disease in addition to obesity

While GLP-1 drugs were originally developed to treat diabetes, researchers keep finding additional ways these medications can potentially benefit patients.

João Cavalcante, MD, Minneapolis Heart Institute, spoke at the Radiological Society of North America (RSNA) 2023 meeting to try and get more radiologists interested in cardiac imaging to help fill the rising need for cardiac imagers on structural heart teams and a growing number of other types of heart and acute care teams.

Filling the crucial role of multimodality imagers on the heart team

João Cavalcante, MD, spoke at RSNA 2023 about key topics and tried to get more radiologists interested in cardiac imaging.